会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 71. 发明申请
    • COMPOSITIONS IN POWDER FORM MADE OF SOFT AGGLOMERATES OF A MICRONIZED DRUG AND OF A TWO-COMPONENTS EXCIPIENT, AND PROCESS FOR THEIR PREPARATION
    • 一种微量药物和两种组分的软组合粉末形式的组合物及其制备方法
    • US20100233276A1
    • 2010-09-16
    • US12734300
    • 2007-10-26
    • Renata RaffinPaolo ColomboFabio SonvicoGaia ColomboAlessandra RossiFrancesca Buttini
    • Renata RaffinPaolo ColomboFabio SonvicoGaia ColomboAlessandra RossiFrancesca Buttini
    • A61K9/14A61K9/50A61K9/58A61K9/60A61K9/62A61K9/64
    • A61K9/1617A61K9/1623
    • The described agglomeration of drug microparticles blended with excipient microparticles is a technique for the size enlargement of micronized products that could be damaged by granulation or compaction techniques. These agglomerates can be used as oral prompt or delayed-release dosage forms administered as they are or dispersed in a liquid. The composition and quantity of the excipient microparticles resulted to be the crucial factors for the agglomerate quality. Therefore, adjusting the content of surface-active agent between 8-20%, of the excipient microparticles it is possible to agglomerate microparticles of drugs that could not be agglomerated per se. Increasing the surfactant concentration in the spray-dried excipient microparticles or increasing the fraction of these excipient microparticles in the blend, the agglomeration was improved. The spray drying technique concentrates the surface-active agent on the microparticle surface. By tumbling, the surface-active agent present on microparticles excipient surface was spread to fill the inter-particle interstices of drug particles giving rise to more resistant agglomerates. This phenomenon occurred also by vibration; the production in this case was quicker.
    • 与赋形剂微粒混合的药物微粒的所述团聚是用于通过造粒或压实技术损坏的微粉化产品的尺寸增大的技术。 这些附聚物可以作为口服或缓释剂型使用,或者分散在液体中。 赋形剂微粒的组成和数量是聚集质量的关键因素。 因此,调整表面活性剂的含量在8〜20%之间,赋形剂微粒可能聚集本身不能团聚的药物微粒。 增加喷雾干燥的赋形剂微粒中的表面活性剂浓度或增加共混物中这些赋形剂微粒的分数,聚集得到改善。 喷雾干燥技术将表面活性剂浓缩在微粒表面上。 通过翻滚,存在于微粒赋形剂表面上的表面活性剂被扩散以填充药物颗粒的颗粒间隙,从而产生更多的抗凝结物质。 这种现象也是由振动引起的。 在这种情况下的生产更快。
    • 72. 发明申请
    • PRESSURE SENSOR DEVICE
    • 压力传感器装置
    • US20100011871A1
    • 2010-01-21
    • US12520641
    • 2007-12-18
    • Marco BigliatiPaolo ColomboGiorglo MartinengoDaniel Verner MuellerMauro Zorzetto
    • Marco BigliatiPaolo ColomboGiorglo MartinengoDaniel Verner MuellerMauro Zorzetto
    • G01L9/00
    • G01L9/0052G01L19/0672G01L19/143G01L19/147
    • A pressure-sensor device (1) comprises:—a pressure-sensitive component (9) having a body, defined in which is a blind cavity, and having a membrane portion (9a), operatively associated to which is a detection element (R); and—a connection structure (2), which has a duct in communication with the cavity of the pressure-sensitive component (9) and is to receive a fluid, a pressure of which is to be detected. The connection structure (2) comprises a supporting body (2a) of the pressure-sensitive component (9), which defines a respective passage (2b), and a compressible element (12, 18) that is designed to be in contact with the fluid and is configured for compensating possible variations of volume thereof. The compressible element (12, 18) is positioned at least in part within the cavity (11) of the pressure-sensitive component (9) and/or in a stretch of the passage (2b) of the supporting body (2a) that is close to the cavity (11) of the pressure-sensitive component (9).
    • 一种压力传感器装置(1)包括: - 具有主体的压敏部件(9),其限定为盲腔,并且具有膜部分(9a),其可操作地与检测元件(R ); 和连接结构(2),其具有与压敏部件(9)的空腔连通的管道,并且接收要被检测的压力的流体。 连接结构(2)包括限定相应通道(2b)的压敏部件(9)的支撑体(2a)和设计成与所述压力敏感部件(9)接触的可压缩元件(12,18) 并且被配置为补偿其体积的可能变化。 可压缩元件(12,18)至少部分地位于压敏部件(9)的空腔(11)内和/或定位在支撑体(2a)的通道(2b) 靠近压敏部件(9)的空腔(11)。
    • 75. 发明申请
    • Insulin highly respirable microparticles
    • 胰岛素高度可呼吸的微粒
    • US20070154404A1
    • 2007-07-05
    • US10593861
    • 2004-03-26
    • Paolo ColomboStefano CagnaniPaolo Ventura
    • Paolo ColomboStefano CagnaniPaolo Ventura
    • A61K38/28A61K9/14
    • A61K9/0075A61K9/1688A61K38/28
    • The invention describes novel dried powders of peptide therapeutic agent useful for producing highly respirable aerosols and the methods for their manufacture. Insulin is the peptide therapeutic agent in the preferred embodiment. The powders of insulin prepared for pulmonary administration are characterized by the peculiar structure and shape of the microparticles that allow the powder to flow and to be easy aerosolized. Typical dry powder of insulin described in this patent show corrugated, nonagglomerated microparticles with a low tapped density. The mean geometric diameter (particle size) ranges between 1.0 and 10.0 micron and the mass median aerodynamic diameter (MMAD) ranges between 1.0 and 4.0 micron. These insulin pulmonary powders exhibit in vitro a very high respirable fraction (>75%).
    • 本发明描述了用于生产高吸入性气溶胶的肽治疗剂的新颖干粉及其制备方法。 胰岛素是优选实施方案中的肽治疗剂。 制备用于肺部给药的胰岛素粉末的特征在于允许粉末流动并易于雾化的微粒的特殊结构和形状。 在该专利中描述的典型的胰岛素干粉末显示具有低抽头密度的波纹状,非团聚微粒。 平均几何直径(粒径)在1.0和10.0微米之间,质量中值空气动力学直径(MMAD)在1.0和4.0微米之间。 这些胰岛素肺粉末在体外表现出非常高的可呼吸分数(> 75%)。
    • 77. 发明申请
    • Protection system of a vehicle battery
    • 汽车电池保护系统
    • US20050212491A1
    • 2005-09-29
    • US10521353
    • 2003-07-30
    • Paolo ColomboMarco Bigliati
    • Paolo ColomboMarco Bigliati
    • H02J7/00
    • H02J7/0032
    • A system for protecting the battery of a vehicle comprises a device (1) for electrically disconnecting of connecting the battery (BA) with respect to an electric load (CS); the device (1) comprises switch means (20, 21) and a microprocessor control circuit (15). The control circuit (15) comprises means for calculating a mean value of voltage of the battery (BA) and comparing it with a threshold value, in order to control the switch means (20, 21). The threshold value is variable as a function of the ambient temperature and the time of inactivity of the motor, and the switch means comprises a bistable electromagnetic arrangement, capable of passing from a first to a second stable condition following a pulse generated by the control circuit (15).
    • 一种用于保护车辆电池的系统包括用于相对于电负载(CS)电连接电池(BA)的装置(1); 装置(1)包括开关装置(20,21)和微处理器控制电路(15)。 控制电路(15)包括用于计算电池(BA)的电压的平均值并将其与阈值进行比较的装置,以便控制开关装置(20,21)。 阈值是随着环境温度和电动机不活动的时间的变化而变化的,并且开关装置包括双稳态电磁装置,其能够在由控制电路产生的脉冲之后从第一稳定状态传递到第二稳定状态 (15)。
    • 80. 发明授权
    • ESD protection network for circuit structures formed in a semiconductor
    • 用于在半导体中形成的电路结构的ESD保护网络
    • US06266222B1
    • 2001-07-24
    • US09223621
    • 1998-12-30
    • Paolo ColomboJacopo MulattiRoberto AnnunziataGiovanni CampardoMarco Maccarrone
    • Paolo ColomboJacopo MulattiRoberto AnnunziataGiovanni CampardoMarco Maccarrone
    • H02H904
    • H01L27/0259H01L27/0251
    • An ESD protection network protects a CMOS circuit structure integrated in a semiconductor substrate. The circuit structure includes discrete circuit blocks formed in respective substrate portions which are electrically isolated from one another and independently powered from at least one primary voltage supply having a respective primary ground, and from at least one secondary voltage supply having a respective secondary ground. This network includes a first ESD protection element for an input stage of the circuit structure; a second ESD protection element for an output stage of the circuit structure, the first and second protection elements having an input/output pad of the integrated circuit structure in common; a first ESD protection element between the primary supply and the primary ground; and a second ESD protection element between the secondary supply and the secondary ground.
    • ESD保护网络保护集成在半导体衬底中的CMOS电路结构。 电路结构包括形成在相应的衬底部分中的分立电路块,它们彼此电绝缘并且由至少一个具有各自的初级接地的初级电压源以及至少一个具有相应次级接地的次级电压源独立供电。 该网络包括用于电路结构的输入级的第一ESD保护元件; 用于所述电路结构的输出级的第二ESD保护元件,所述第一和第二保护元件具有所述集成电路结构的输入/输出焊盘; 主要供电和主地面之间的第一个ESD保护元件; 以及在次级电源和次级接地之间的第二ESD保护元件。